| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | n/a | n/a |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 0.15 | (4.95) | (2.59)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 0.66 | (7.80) | (3.67)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 2.17 | (5.29) | (2.24)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 4.17 | (4.76) | (2.26)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 8.19 | (8.74) | (2.60)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Capital Allocation Plan based on M&A successes | 20-Oct-2025 | 07:00 | RNS |
| Kailera Therapeutics announces Series B financing | 15-Oct-2025 | 07:00 | RNS |
| Monthly Valuation Update and Factsheet | 14-Oct-2025 | 07:00 | RNS |
No recent information was found.
No deals were found in the last 28 days.
| Currency | US Dollars |
| Share Price | $ 1.70 |
| Change Today | $ 0.01 |
| % Change | 0.59 % |
| 52 Week High | $1.7 |
| 52 Week Low | $1.1 |
| Volume | 1,505,921 |
| Shares Issued | 327.32m |
| Market Cap | $556.45m |
| RiskGrade | 206 |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:08 | 300,000 @ $1.70 |
| 16:35 | 5 @ $1.70 |
| 16:35 | 4,786 @ $1.70 |
| 16:35 | 14 @ $1.70 |
| 16:35 | 221 @ $1.70 |
| Chair | William (Bill) Simpson |
You are here: research